Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2024 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
ADVM
Shares outstanding
22,107,985
Price per share
$4.36
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
0
Total reported value
$0
Share change
-10,508,904
Value change
-$47,605,774
Number of holders
0
Price from insider filings
$4.36
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Rush Ryan Bradford 5.1% $3,055,500 1,050,000 Rush Ryan Bradford 17 Dec 2024
BlackRock, Inc. 2% $895,288 414,485 BlackRock, Inc. 30 Jun 2025

As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM). This represents 0% of the company’s total 22,107,985 outstanding shares.

Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$47,605,774 $4.36 0
2025 Q3 13,566,970 $61,458,813 +$897,363 $4.53 48
2025 Q2 13,503,213 $29,035,276 -$9,430,367 $2.15 57
2025 Q1 15,830,355 $67,598,655 +$2,134,875 $4.37 69
2024 Q4 15,367,331 $71,762,612 -$19,025,186 $4.67 66
2024 Q3 16,433,840 $116,616,020 +$7,083,173 $7.02 74
2024 Q2 14,520,480 $99,630,518 +$7,101,493 $6.86 64
2024 Q1 13,170,929 $186,240,391 +$186,240,391 $14.14 56